NCT01466296

Brief Summary

The overall objective is to improve the functional status of Middle East adolescents with disabilities due to cerebral palsy (CP) and disabilities in adults due to cerebro-vascular stroke (Hemiplegia) by a collaborative Jordanian-Israeli-Palestinian-Moroccan applied research project.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Oct 2010

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 5, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 7, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

November 7, 2011

Status Verified

November 1, 2011

Enrollment Period

6 months

First QC Date

September 5, 2011

Last Update Submit

November 3, 2011

Conditions

Keywords

CERBRAL PALSYPoststroke/CVA ParesisREHABILITATIONWALKINGPERUTURBATION

Outcome Measures

Primary Outcomes (1)

  • 10 meter walk test (10MWT)

    10-meter walk test (Rossier \& Wade, 2001) will assess normal walking speed. The participant walks a straight path distance of 10 meters at normal walking speed with time recorded. The test will be performed twice with the number of steps counted. The tester or an assistant remains near the participant to prevent a fall or injury if they appear unsteady.

Secondary Outcomes (4)

  • 6 Minuets Walk Test (6MinWT)

  • Mechanical Efficiency

  • WHOQOL-BREF

  • Berg Balance Scale (BBS)

Study Arms (3)

Re-Step

EXPERIMENTAL

Mechatronic shoe with a sole made to change slopes in the swing phase of walking. This unpredictable change will introduce a situation of necessary adaptation to keep balance

Device: Chaotic Perturbation

Dummy shoes

EXPERIMENTAL

The shoes are in the same shape and weight of the Re-Step without the perturbations.

Device: Dummy not active shoes

treadmill

ACTIVE COMPARATOR

A treadmill with safety adaptation and all the usual characteristics of speed and slopes of fitness treadmills.

Device: Treadmill training

Interventions

Each subject will undergo 36 intervention sessions, 3 times per week over 12 weeks. Each session will last up to 45 minuets, depending on the subject's endurance. During each session the subject will perform basic stretching and muscle strengthening, then wear the random shoes and perform a set of exercises following specific verbal tasks, e.g., "Walk 5 strides forward," or, "Walk to the right side until I ask you to stop." During this stage of walking the device will impose perturbations in the range tolerated by the subject. The therapist will make a written report of each session.

Also known as: Re-Step shoes
Re-Step

Each subject will undergo 36 intervention sessions, 3 times per week over 12 weeks. Each session will last up to 45 minuets, depending on the subject's endurance. During each session the subject will perform basic stretching and muscle strengthening, then wear the dummy shoes and perform a set of exercises following specific verbal tasks, e.g., "Walk 5 strides forward," or, "Walk to the right side until I ask you to stop." During this stage of walking the device will not impose perturbations. The therapist will make a written report of each session.

Also known as: Dummy Shoes
Dummy shoes

Each subject will undergo 36 intervention sessions, 3 times per week over 12 weeks. Each session will last up to 45 minuets, depending on the subject's endurance. During each session the subject will exercise basic stretching and muscle strengthening, then walk on the treadmill. A physiotherapist according the subject's rate of improvement will determine the increase in treadmill velocity and slope. The therapist will make a written report after each session.

Also known as: Treadmill
treadmill

Eligibility Criteria

Age14 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of cerebral palsy
  • Predominantly spastic type of CP with distribution of diplegia / tetraplegia
  • Age: 14 - 20 yr
  • GMFCS (gross motor function classification system) at levels II \& III
  • A cognitive level sufficient to comprehend and cooperate in treatment and testing
  • No orthopedic surgery or other tone reduction intervention in last 6 months
  • Not a candidate for orthopedic surgical or other tone reduction intervention.

You may not qualify if:

  • Candidates for orthopedic surgical or any other tone reduction procedures, e.g., botulin injections, baclofen pump interventions
  • Cannot cooperate in treatment or understand instructions
  • Uncontrolled convulsions if epileptic
  • Adolescents with progressive degenerative conditions of CNS or/and muscle-skeletal system.
  • Stroke survivors in chronic stage (1 year or more following stroke
  • Age: 40 - 65 yr
  • Mild to moderate gait with ability to ambulate \> 10m with or without assistive device
  • Cognitive level sufficient to comprehend and cooperate in tests and training
  • Mini-mental state examination (MMSE) score \> 24 6: Receive medical clearance from their family physician.
  • Dementia (Mini-Mental Score \< 24)
  • Severe aphasia
  • Heart failure
  • Other medical conditions that preclude participation in low-intensity treadmill walking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assaf Harofeh Medical Center

Ẕerifin, 70300, Israel

RECRUITING

Related Publications (1)

  • Harries N, Loeppky JA, Shaheen S, Al-Jarrah M, Molteni F, Hutzler Y, Bar-Haim S; MESF Project. A stair-climbing test for measuring mechanical efficiency of ambulation in adults with chronic stroke. Disabil Rehabil. 2015;37(11):1004-8. doi: 10.3109/09638288.2014.948131. Epub 2014 Aug 12.

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Study Officials

  • Eli Lahat, MD Proffesor

    Assaf-Harofeh Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Simona Bar-Haim, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator: Professor Eli Lahat

Study Record Dates

First Submitted

September 5, 2011

First Posted

November 7, 2011

Study Start

October 1, 2010

Primary Completion

April 1, 2011

Study Completion

April 1, 2012

Last Updated

November 7, 2011

Record last verified: 2011-11

Locations